NEW YORK, June 3 /PRNewswire/ -- Carl Icahn announced today that Biogen is acting in its usual shareholder unfriendly way by manipulating the annual meeting of shareholders in order the prevent the votes that have been submitted from being counted. They are doing so in order to attempt to keep two of the Icahn nominees from winning seats on the Board. If the Board is successful, Richard Mulligan, a prominent scientist and physician, may be kept from legitimately being elected to the Board. This is a consistent theme of this Board. Do everything possible to keep shareholders from entering into the Board’s private club to ensure that shareholders are kept in the dark about what the Board is doing, just as they were about last year’s sale process. Mr. Icahn concluded that “shareholders should demand that this Board finally act in their interest instead of just attempting to relect themselves. There is absolutely no reason to adjourn the meeting for hours in order to keep the polls open. Do not let them get away with hijacking the election.”
CONTACT: Susan Gordon for Carl Icahn, +1-212-702-4309
